Top Markets
#1 Black Phoenix Black Phoenix +354.85%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.17%
#4 Akedo Akedo +51.00%
#5 Acurast Acurast +31.40%
#6 BasedHype BasedHype +23.42%
#7 Cryptopia Cryptopia +21.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.41%
#9 Avantis Avantis +19.21%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +15.52%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Rank in Stocks #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Share Price
$0.02765
Last synced: 2024-12-23
Market Cap
$69.04K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Histogen Inc. (HSTO)

Category

Healthcare
Operating Margin for Histogen Inc. (HSTO)
Operating Margin as of August 2026 TTM: -282.38%
According to Histogen Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is -282.38%. At the end of 2021 the company had an Operating Margin of -1,681.94%.
Operating Margin history for Histogen Inc. from 2011 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -282.38% 0.00%
2022 -282.38% -83.21%
2021 -1,681.94% 195.64%
2020 -568.92% 442.76%
2019 -104.82% 92.61%
2018 -54.42% 9.70%
2017 -49.61% -98.67%
2016 -3,733.45% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -100.14%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.11%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.